Related Experiment Video
Updated: Dec 17, 2025

Using an Automated Cell Counter to Simplify Gene Expression Studies: siRNA Knockdown of IL-4 Dependent Gene Expression in Namalwa Cells
Published on: April 14, 2010
NLRC3 silencing accelerates the invasion of hepatocellular carcinoma cell via IL-6/JAK2/STAT3 pathway activation
Jian-Hua Kang1, Ming-Jie Li1, Pei-Pei Luan2
1Department of Endocrinology, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
Abstract:
Nucleotide-binding domain, leucine-rich repeat family with a caspase activation and recruitment domain 3 (NLRC3) participates in both immunity and cancer. The aim of this study was to determine the role of NLRC3 in human hepatocellular carcinoma (HCC) and the underlying mechanisms. We collected human liver tissues from nonalcoholic steatohepatitis (NASH), HCC, and adjacent normal tissues to characterize the pattern of NLRC3 expression by real-time quantitative polymerase chain reaction and immunohistochemistry. Then, we used the HCC cell line, HuH-7, transfected with small interfering RNA to silence the NLRC3 expression. 5-Ethynyl-2'-deoxyuridine assay, scratch assay, and transwell invasion assay were used for assessing proliferation, migration, and invasion, respectively. Flow cytometry and terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay were conducted to assess cell apoptosis. The expression of NLRC3 was reduced in human HCC tissues, compared with normal liver and nonalcoholic steatohepatitis tissues. After knocking down of NLRC3, the proliferation, migration, and invasion were increased in HuH-7 cells. And flow cytometry and TUNEL assay showed that HuH-7 cell apoptosis was suppressed after NLRC3 knockdown. As for the underlying mechanisms, knockdown of NLRC3 in HuH-7 cells was associated with the activation of Janus kinase 2/signal transducers and activators of transcription 3 (JAK2/STAT3) pathway under interleukin-6 (IL-6) stimulation. NLRC3 expression was downregulated in human HCC tissues. NLRC3 silencing in HuH-7 cells can promote the proliferation, migration, and invasion of hepatocellular carcinoma cells. JAK2/STAT3 pathway activation induced by IL-6 may be the underlying mechanism for HCC when NLRC3 expression is silenced. And the invasion of HuH-7 cells was partially suppressed by the STAT3 specific inhibitor (cryptotanshinone). Therefore, NLRC3 may play a significant role in HCC and might be a therapeutic target for the treatment of HCC.
Insights
Nucleotide-binding domain, leucine-rich repeat family with a caspase activation and recruitment domain 3 (NLRC3) is reduced in hepatocellular carcinoma (HCC). Silencing NLRC3 promotes HCC cell growth and invasion via the JAK2/STAT3 pathway, suggesting NLRC3 as a potential therapeutic target.
Area of Science:
- Oncology
- Immunology
- Molecular Biology
Background:
- Nucleotide-binding domain, leucine-rich repeat family with a caspase activation and recruitment domain 3 (NLRC3) is implicated in immune responses and cancer development.
- The specific role and underlying mechanisms of NLRC3 in human hepatocellular carcinoma (HCC) remain to be fully elucidated.
Purpose of the Study:
- To investigate the expression patterns of NLRC3 in human HCC tissues.
- To determine the functional role of NLRC3 in HCC cell proliferation, migration, invasion, and apoptosis.
- To elucidate the molecular mechanisms by which NLRC3 influences HCC progression, particularly the involvement of the JAK2/STAT3 pathway.
Main Methods:
- NLRC3 expression was analyzed in human liver tissues (HCC, NASH, normal) using real-time quantitative PCR and immunohistochemistry.
- HCC cell line (HuH-7) was used to assess the effects of NLRC3 knockdown via small interfering RNA (siRNA).
- Cell proliferation, migration, invasion, and apoptosis were evaluated using EdU, scratch, Transwell, flow cytometry, and TUNEL assays, respectively.
- The JAK2/STAT3 pathway activation under IL-6 stimulation was assessed following NLRC3 knockdown, with STAT3 inhibition using cryptotanshinone.
Main Results:
- NLRC3 expression was significantly reduced in human HCC tissues compared to normal and NASH liver tissues.
- NLRC3 knockdown in HuH-7 cells led to increased proliferation, migration, and invasion, and suppressed apoptosis.
- NLRC3 silencing was associated with enhanced IL-6-induced JAK2/STAT3 pathway activation in HCC cells.
- Inhibition of STAT3 partially reversed the increased invasion of HuH-7 cells after NLRC3 knockdown.
Conclusions:
- NLRC3 plays a suppressive role in human hepatocellular carcinoma.
- Downregulation of NLRC3 promotes HCC progression by enhancing cell proliferation, migration, and invasion, potentially through the activation of the IL-6/JAK2/STAT3 signaling pathway.
- NLRC3 represents a potential therapeutic target for HCC treatment.
More Related Videos
10:16SorLA and CLC:CLF-1-dependent Downregulation of CNTFRα as Demonstrated by Western Blotting, Inhibition of Lysosomal Enzymes, and Immunocytochemistry
Published on: January 6, 2017
07:23Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome
Published on: June 15, 2016
Related Concept Videos
Experimental RNAi
The JAK-STAT Signaling Pathway
MicroRNAs
PI3K/mTOR/AKT Signaling Pathway
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...